Organogenesis Holdings Inc. provided earnings guidance for the year ending December 31, 2022. For the year, the company expected net revenue of between $485 million and $515 million, representing an increase of approximately 4% to 10% year-over-year as compared to net revenue of $468.1 million for the year ended December 31, 2021.